India drives nutraceutical export expansion amid 13.6% market CAGR target
The Indian Ministry of Commerce & Industry targets significant export growth for its nutraceutical sector, leveraging traditional wellness and modern science at the Bharat Nutraverse Expo.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
New Delhi, India — 07 July 2026 – The Indian government is actively promoting its nutraceutical sector, focusing on increased global export opportunities through initiatives like the Bharat Nutraverse Expo 2026. Organised by the Shellac and Forest Products Export Promotion Council (SHEFEXIL), under the Ministry of Commerce & Industry, the expo aims to position India as a strategic partner in the global nutraceutical supply chain, bridging traditional wellness with modern nutritional science. The event, scheduled for 7-9 September in New Delhi, will draw suppliers and finished product brands, including confirmed exhibitors like Siddhayu Life Sciences, Arjuna Natural, Bio Gen Extracts, K. Patel Phyto Extractions, and Sami-Sabinsa Group.
Dr. Debjani Roy, Executive Director of SHEFEXIL, highlights robust growth in Indian nutraceutical and botanical exports, driven by rising global demand for preventative health, healthy ageing, and plant-based solutions. She notes a strategic shift from commodity exports towards higher-value, science-backed products. India's nutraceutical market, as reported by the Ministry of Food Processing Industries, is forecast to achieve a 13.6% Compound Annual Growth Rate (CAGR) between 2025 and 2030, building on its 9.22% share of the global nutraceutical market in 2023. Key export markets currently include the US, Europe, and the Middle East, with plans for expansion into Asia-Pacific, Oceania, Africa, and Latin America. Dominant export ingredients include Ashwagandha, Bacopa, Boswellia, and Curcumin.
Indian companies are increasing investment in clinical research, product innovation, novel delivery formats, and consumer-centric formulations. Government support through initiatives promoting food processing and scientific validation of traditional knowledge is also contributing to sector growth. This shift aims to transition India from a primary sourcing destination to a hub for innovation, manufacturing, and research. Domestic acquisitions, such as Hindustan Unilever's purchase of OZiva and USV Pharma's 79% stake in Wellbeing Nutrition, underscore the internal market's dynamism and potential for brand consolidation. The expo also facilitates international collaboration, with Thailand participating as a partner country to explore market access in India, exemplified by Singapore-based LAC's recent product launch in India via JVKM Consultants India Pvt. Ltd.
What this means for United Kingdom
UK brand owners and procurement leads face an opportunity to diversify their supply chains and access high-value, science-backed active ingredients and finished products from India. The 13.6% projected CAGR for the Indian nutraceutical market suggests competitive pricing and increasing innovation, particularly in botanicals like Ashwagandha and Curcumin. Manufacturers should assess Indian suppliers for MOQs, lead times, and regulatory compliance, particularly regarding novel food status for certain botanicals under FSA/MHRA guidelines. This presents a chance for reformulation, leveraging traditional Indian ingredients validated by modern science to differentiate product offerings and capture consumer interest in natural, evidence-based solutions.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.